Literature DB >> 17055788

Human complement factor I glycosylation: structural and functional characterisation of the N-linked oligosaccharides.

Stefanos A Tsiftsoglou1, James N Arnold, Pietro Roversi, Max D Crispin, Catherine Radcliffe, Susan M Lea, Raymond A Dwek, Pauline M Rudd, Robert B Sim.   

Abstract

Factor I (fI) is a key serine protease that modulates the complement cascade by regulating the levels of C3 convertases. Human fI circulates in plasma as a heavily N-glycosylated (25-27% w/w) heterodimer composed of two disulphide linked chains, each carrying three N-linked oligosaccharide chains. It had been suggested that the oligosaccharides may have both structural and functional roles in the interactions with the natural substrate and the cofactor during a catalysis. The N-linked glycans of each fI chain were characterised in detail and the analysis revealed a similar composition of the glycan pools with both chains heavily sialylated. Disialylated structures were in excess over monosialylated ones: 55% over 40% for the heavy chain and 62% over 35% for the light chain. The dominant type of glycan identified on both chains was A(2)G(2)S(2), a biantennary structure with chains terminating in sialic acid linked to galactose. The glycan characterisation facilitated a strategy for the partial deglycosylation of the enzyme. Assessment of the proteolytic activities of the native and partially deglycosylated forms of fI showed that both forms of the enzyme have very similar proteolytic activities against C3(NH(3)) indicating that the charged glycans of fI do not influence the fI-cofactor-substrate interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055788     DOI: 10.1016/j.bbapap.2006.09.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Analysis of binding sites on complement factor I using artificial N-linked glycosylation.

Authors:  Jose I Sanchez-Gallego; Tom W L Groeneveld; Stefanie Krentz; Sara C Nilsson; Bruno O Villoutreix; Anna M Blom
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

2.  Enhanced expression of the complement factor H mRNA in proliferating human RPE cells.

Authors:  Norbert Kociok; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-08       Impact factor: 3.117

3.  Characterization of shark complement factor I gene(s): genomic analysis of a novel shark-specific sequence.

Authors:  Dong-Ho Shin; Barbara M Webb; Miki Nakao; Sylvia L Smith
Journal:  Mol Immunol       Date:  2009-05-07       Impact factor: 4.407

4.  Analysis of binding sites on complement factor I that are required for its activity.

Authors:  Sara C Nilsson; Izabela Nita; Lisa Månsson; Tom W L Groeneveld; Leendert A Trouw; Bruno O Villoutreix; Anna M Blom
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

5.  Early Versus Late Diagnosis of Complement Factor I Deficiency: Clinical Consequences Illustrated in Two Families with Novel Homozygous CFI Mutations.

Authors:  Clara Franco-Jarava; Elena Álvarez de la Campa; Xavier Solanich; Francisco Morandeira-Rego; Virgínia Mas-Bosch; Marina García-Prat; Xavier de la Cruz; Andrea Martín-Nalda; Pere Soler-Palacín; Manuel Hernández-González; Roger Colobran
Journal:  J Clin Immunol       Date:  2017-09-23       Impact factor: 8.317

6.  Three surface exoglycosidases from Streptococcus pneumoniae, NanA, BgaA, and StrH, promote resistance to opsonophagocytic killing by human neutrophils.

Authors:  Ankur B Dalia; Alistair J Standish; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2010-02-16       Impact factor: 3.441

7.  Structural basis for complement factor I control and its disease-associated sequence polymorphisms.

Authors:  Pietro Roversi; Steven Johnson; Joseph J E Caesar; Florence McLean; Kirstin J Leath; Stefanos A Tsiftsoglou; B Paul Morgan; Claire L Harris; Robert B Sim; Susan M Lea
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

8.  Complement factor I deficiency: a not so rare immune defect: characterization of new mutations and the first large gene deletion.

Authors:  María Alba-Domínguez; Alberto López-Lera; Sofía Garrido; Pilar Nozal; Ignacio González-Granado; Josefa Melero; Pere Soler-Palacín; Carmen Cámara; Margarita López-Trascasa
Journal:  Orphanet J Rare Dis       Date:  2012-06-18       Impact factor: 4.123

9.  Chemical labelling of active serum thioester proteins for quantification.

Authors:  Lotta Holm; Gareth L Ackland; Mark R Edwards; Ross A Breckenridge; Robert B Sim; John Offer
Journal:  Immunobiology       Date:  2011-07-23       Impact factor: 3.144

10.  A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity.

Authors:  Shihui Guo; Wolfgang Skala; Viktor Magdolen; Peter Briza; Martin L Biniossek; Oliver Schilling; Josef Kellermann; Hans Brandstetter; Peter Goettig
Journal:  J Biol Chem       Date:  2015-11-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.